Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.

Link to article at PubMed

Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.

Circulation. 2012 Jan 3;125(1):159-64

Authors: Granger CB, Armaganijan LV

PMID: 22215890 [PubMed - in process]

Leave a Reply

Your email address will not be published. Required fields are marked *